<DOC>
	<DOC>NCT01027013</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of rebamipide 2% suspension for the treatment of patients with dry-eye.</brief_summary>
	<brief_title>Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Age 18 years and older Diagnosis of dry eye as defined by the protocol Ongoing ocular disease that may interfere with study parameters. Inability to stop using topical ophthalmic medications throughout the duration of the study Inability to stop the use of contact lenses for the duration of the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>